Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
      Description

      Safety, Efficacy, PK and PD of CTAP101 (calcifediol) ER Capsules for SHPT in HD Patients VDI

      Conditions
      Secondary Hyperparathyroidism Due to Renal CausesChronic Kidney DiseasesVitamin D DeficiencyStage 5 Chronic Kidney Disease
      Talk to us
      COMPLETED
      Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency
      Description

      An Open-Label, Repeated-Dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Oral CTAP101 Capsules, Immediate- Release (IR) Calcifediol, High-Dose Cholecalciferol, and Paricalcitol Plus Low-Dose Cholecalciferol in Patients with Secondary Hyperparathyroidism, Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency

      Conditions
      Secondary Hyperparathyroidism Due to Renal CausesVitamin D InsufficiencyCKD Stage 3CKD Stage 4
      Talk to us